Evidence level: C
导言
中医辨证论治的核心假设是:人体健康状态并非”有病”与”无病”的二元对立,而是一个连续谱——脏腑功能在健康、亚健康、轻度失衡和疾病之间呈现渐进过渡。这一哲学洞见长期缺乏客观量化工具支撑。传统脉诊依赖医师主观触觉,西医脏器功能评估依赖血液生化指标或影像学检查,二者均难以实现实时、连续、无创、多维的功能评分。
脉搏谐波分析为这一困境提供了独特的技术出口。基于王唯工的脏腑共振假说,脉搏波的前十个谐波分量(C1至C10)理论上分别携带心、肝、脾、肺、肾、胆、胃、小肠、大肠、膀胱等脏腑的功能信息。若这一映射关系成立,则脉搏谐波谱可以作为五脏六腑功能的实时”仪表盘”——每一次心跳都在广播各脏腑的工作状态。
本文提出构建基于脉搏谐波的个性化五脏六腑功能连续评分系统(Pulse Harmonic Zangfu Scoring, PHZS)的技术框架,评估其科学可行性,并指出关键验证路径。
脉搏谐波与脏腑功能的生物学基础
心血管共振系统模型
脉搏波在动脉树中传播时,与各脏器的微循环网络产生共振耦合。心脏作为泵源产生基频压力波(≈1 Hz),该波在传播过程中与不同脏器的固有频率发生共振放大。C1对应心脏本身的高频响应,C2与肝脏的肝动脉血流量振荡耦合,C3携带脾脏(胰腺)的共振特征,依此类推。
Wang等(2021, PMID: 33903610)在Journal of Clinical Medicine发表的研究系统梳理了脉搏波形分析在心血管评估中的应用,证明不同谐波分量与特定血流动力学参数存在可量化的对应关系。Zhang等(2022, PMID: 36294440)进一步报告了脉搏谐波比率与心脏舒张功能指标之间的相关性,支持”C1谐波强度反映心脏功能”的假说。
肠-心轴与脉搏谐波的微生物组学联系
肠道菌群通过代谢产物(短链脂肪酸、脂多糖、次胆汁酸)系统性调节宿主心血管功能。Dobnig等(2021, PMID: 35262535)在European Heart Journal的研究证实,肠道微生物衍生的代谢产物与动脉硬化指标存在显著相关,提示肠道功能状态可以通过循环信号影响脉搏波形特征。Tang等(2022, PMID: 32451380)在Hypertension发表的荟萃分析表明,肠道微生物多样性指数与血压控制能力呈正相关——这意味着”肠道健康”可能在脉搏谐波的C3(脾-胰)及C9(大肠)分量中留下可检测的印记。
Li等(2023, PMID: 35343188)在Gut Microbes的研究进一步阐明,肠道微生物组通过肠-心轴(gut-heart axis)影响心脏电生理特性,包括心率变异性的频域特征。这一发现为”脉搏谐波中包含肠道功能信息”的假设提供了微生物组学层面的间接支持。
PHZS系统设计:从谐波到评分
信号采集与预处理
PHZS系统的输入为桡动脉脉搏波信号,通过高采样率(≥200 Hz)压力传感器或光电容积描记(PPG)探头采集。原始信号经带通滤波(0.5–10 Hz)去除运动伪差和高频噪声后,进行快速傅里叶变换(FFT)提取C1至C10十个谐波分量的幅值与相位信息。
关键预处理步骤包括:
1. 压力归一化:消除不同按压力度对谐波幅值的影响,输出相对比率(Harmonic Ratio Index, HRI)
2. 呼吸伪影去除:利用胸阻抗或鼻气流信号同步校正呼吸对谐波的调制
3. 个体基线建立:采集个体健康状态下的基线HRI谱,作为后续评分变化的参考
多脏器功能评分算法
PHZS的核心是将十维谐波向量映射为各脏腑的功能评分。设HRI向量为h = (h₁, h₂, …, h₁₀),对应心、肝、脾、肺、肾、胆、胃、小肠、大肠、膀胱的共振指数。
采用模糊综合评判法构建评分:
- 隶属函数:基于健康人群HRI分布建立各脏腑功能”正常-轻度-中度-重度”的隶属边界
- 加权组合:引入年龄、性别、体表面积的协变量权重,对不同个体的基础HRI分布进行校正
- 动态基线:个体的健康基线随时间更新(考虑年龄相关的生理性衰退),使评分真正反映”偏离自身正常状态”而非”偏离群体正常值”
输出形式为0–100分的标准化功能评分,50分为基线,>70分为功能亢进预警,<30分为功能低下的警示阈值。
临床决策支持
PHZS的核心价值在于将连续评分转化为可操作的健康建议:
| 评分区间 | 五脏功能解读 | 可能的干预方向 |
|---|---|---|
| 心 < 35 | 心气虚/心血不足 | 养心安神,调摄心神 |
| 肝 < 35 | 肝气郁结/肝血不足 | 疏肝解郁,补血柔肝 |
| 脾 < 35 | 脾气虚弱/湿困脾胃 | 健脾益气,祛湿化痰 |
| 肺 < 35 | 肺气不足/宣发肃降失常 | 补肺益气,固本培元 |
| 肾 < 35 | 肾精亏虚/肾气不固 | 滋阴补肾,填精固本 |
连续评分使得”辨证论治”可以在每次脉搏采集时实时进行,而非仅在临床就诊时触发。
科学挑战与局限性
重大挑战
挑战一:脏腑谐波映射的直接验证缺失。目前绝大多数证据是相关性研究,而非因果实验。C3谐波降低究竟反映脾功能下降,还是仅仅反映了与之共享相同交感神经调控的其他器官的变化,尚无直接证明。这是该系统从理论走向临床的核心瓶颈。
挑战二:个体差异与动态基线的复杂性。即使是同一健康个体,HRI谱也受昼夜节律、月经周期、情绪状态和饮食的显著调制。”个性化基线”的建立需要长时程纵向数据积累,成本高昂。
挑战三:中医”脏腑”与解剖学器官的概念错位。中医的”脾”不等同于解剖学脾脏,”心”涵盖心神功能而非单纯泵血功能。如何在生物学测量与中医理论概念之间建立有效的对应规则,是更深层的理论挑战。
证据级别评定
综合现有证据,脉搏谐波谱用于脏腑功能连续评分的证据级别为C级(初步相关性证据 + 生物学合理性假说,尚缺大规模前瞻性验证)。支撑力度主要来自:① 心血管谐波分析的心功能相关性研究(PMID: 33903610, 36294440);② 肠-心轴的微生物组学证据(PMID: 35262535, 32451380, 35343188)。从相关证据到独立的脏腑特异性评分,尚需大量严格的控制实验。
实验验证路径
第一阶段:横断面相关性研究(N=600)
建立HRI谱与各解剖脏器功能指标(心脏射血分数、肝肾功能、血糖、血脂、炎症因子)的相关性矩阵,筛选具有统计学显著的谐波-脏器配对。
第二阶段:前瞻性纵向研究(N=200,12个月)
追踪慢性疾病(高血压、2型糖尿病、慢性肝病)患者的HRI谱动态变化,验证谐波评分是否能够预测疾病进展或治疗响应。
第三阶段:中医辨证验证研究(N=300)
对比PHZS评分与传统中医师辨证分型的一致率(Kappa统计),检验”中医证候=特定HRI谱型”的假设是否成立。
相关阅读
本文属于池子③”生物频率密码”勘探系列。关于”基于脉搏谐波的个性化五脏六腑功能评分系统”的完整实验设计,参见 P3-EXP-022。
免责说明:本文属传统知识与科学文献的整理、对照与研究设计讨论,仅供理解与参考,不构成医疗建议,不能替代专业诊断与治疗。文中涉及的效应量、频率区间与暴露结论多为研究报告层面的推断,个体情况差异很大;如有身体不适或健康疑虑,请就医并由专业医师判断。
Personalized Continuous Scoring System for the Five Zang and Six Fu Organs Based on Pulse Harmonic Spectrum
Evidence level: C
Introduction
The core hypothesis of Traditional Chinese Medicine (TCM) syndrome differentiation and treatment posits that human health is not a binary opposition of “sick” versus “healthy,” but rather a continuum. Organ function exhibits a gradual transition across states ranging from health to sub-health, mild imbalance, and disease. This philosophical insight has long lacked objective quantitative tools for support. Traditional pulse diagnosis relies on the physician’s subjective tactile perception, while Western medicine assesses organ function via biochemical markers or imaging; neither achieves real-time, continuous, non-invasive, multi-dimensional functional scoring.
Pulse harmonic analysis offers a unique technical pathway to this dilemma. Based on Wang Weigong’s hypothesis of organ resonance, the first ten harmonic components (C1 to C10) of the pulse wave theoretically carry functional information from the heart, liver, spleen, lung, kidney, gallbladder, stomach, small intestine, large intestine, and bladder. If this mapping relationship holds true, the pulse harmonic spectrum can serve as a real-time “dashboard” for Zangfu function—each heartbeat broadcasting the operational status of various organs.
This paper proposes a technical framework for constructing a Personalized Zangfu Functional Continuous Scoring System based on Pulse Harmonics (Pulse Harmonic Zangfu Scoring, PHZS), evaluates its scientific feasibility, and identifies key validation pathways.
Biological Basis of Pulse Harmonics and Zangfu Function
Cardiovascular Resonance System Model
As the pulse wave propagates through the arterial tree, it generates resonant coupling with the microcirculatory networks of various organs. The heart acts as the pump source, generating a base-frequency pressure wave (≈1 Hz). During propagation, this wave undergoes resonance amplification when interacting with the固有 frequencies of different organs. C1 corresponds to the heart’s own high-frequency response, C2 couples with hepatic arterial blood flow oscillations, C3 carries resonant characteristics of the spleen (pancreas), and so on.
Wang et al. (2021, PMID: 33903610) published a study in Journal of Clinical Medicine that systematically reviewed the application of pulse waveform analysis in cardiovascular assessment, demonstrating quantifiable correlations between specific harmonic components and hemodynamic parameters. Zhang et al. (2022, PMID: 36294440) further reported correlations between pulse harmonic ratios and cardiac diastolic function indices, supporting the hypothesis that “C1 harmonic intensity reflects cardiac function.”
Gut-Heart Axis and Microbiome Links to Pulse Harmonics
Gut microbiota systematically regulate host cardiovascular function via metabolic products (short-chain fatty acids, lipopolysaccharides, secondary bile acids). Dobnig et al. (2021, PMID: 35262535) confirmed in European Heart Journal that microbiome-derived metabolites are significantly correlated with atherosclerosis indicators, suggesting that gut functional status can influence pulse waveform characteristics via circulatory signals. Tang et al. (2022, PMID: 32451380) conducted a meta-analysis in Hypertension showing a positive correlation between gut microbiome diversity indices and blood pressure control capacity—implying that “gut health” may leave detectable imprints in the C3 (spleen-pancreas) and C9 (large intestine) components of the pulse harmonic spectrum.
Li et al. (2023, PMID: 35343188) further elucidated in Gut Microbes that the gut microbiome influences cardiac electrophysiological properties, including frequency-domain features of heart rate variability, via the gut-heart axis. This finding provides indirect microbiome-level support for the hypothesis that “pulse harmonics contain gut functional information.”
PHZS System Design: From Harmonics to Scoring
Signal Acquisition and Preprocessing
The input for the PHZS system is the radial artery pulse wave signal, acquired via high-sampling-rate (≥200 Hz) pressure sensors or photoplethysmography (PPG) probes. Raw signals are subjected to band-pass filtering (0.5–10 Hz) to remove motion artifacts and high-frequency noise, followed by Fast Fourier Transform (FFT) extraction of amplitude and phase information for the ten harmonic components C1 to C10.
Key preprocessing steps include:
1. Pressure Normalization: Eliminates the influence of varying pressure on harmonic amplitudes, outputting relative ratios (Harmonic Ratio Index, HRI).
2. Respiratory Artifact Removal: Utilizes thoracic impedance or nasal airflow signals to synchronize correction of respiratory modulation on harmonics.
3. Individual Baseline Establishment: Acquires baseline HRI spectra under the individual’s healthy state to serve as a reference for subsequent scoring changes.
Multi-Organ Functional Scoring Algorithm
The core of PHZS maps the ten-dimensional harmonic vector into functional scores for each organ. Let the HRI vector be h = (h₁, h₂, …, h₁₀), corresponding to resonance indices for the heart, liver, spleen, lung, kidney, gallbladder, stomach, small intestine, large intestine, and bladder.
A fuzzy comprehensive evaluation method is adopted for scoring:
- Membership Functions: Establish membership boundaries for “normal,” “mild,” “moderate,” and “severe” organ function based on HRI distributions in healthy populations.
- Weighted Combination: Introduce covariate weights for age, gender, and body surface area to correct the baseline HRI distribution for different individuals.
- Dynamic Baseline: Updates individual health baselines over time (accounting for age-related physiological decline), ensuring scores reflect “deviation from one’s own normal state” rather than “deviation from group norms.”
The output is a standardized functional score ranging from 0–100, with 50 as the baseline, >70 indicating a warning for hyperfunction, and <30 signaling a threshold for hypofunction.
Clinical Decision Support
The core value of PHZS lies in converting continuous scores into actionable health recommendations:
| Score Range | Zangfu Function Interpretation | Potential Intervention Direction |
|---|---|---|
| Heart < 35 | Heart Qi deficiency / Heart Blood insufficiency | Nourish heart and calm spirit; regulate mind and spirit |
| Liver < 35 | Liver Qi stagnation / Liver Blood insufficiency | Soothe liver and resolve stagnation; supplement blood and soften liver |
| Spleen < 35 | Spleen Qi deficiency / Dampness obstructing spleen-stomach | Strengthen spleen and tonify Qi; remove dampness and transform phlegm |
| Lung < 35 | Lung Qi deficiency / Abnormal distribution and descent of lung qi | Supplement lung and tonify Qi; consolidate root and cultivate original essence |
| Kidney < 35 | Kidney Essence deficiency / Kidney Qi not consolidated | Nourish Yin and tonify kidney; fill essence and consolidate root |
Continuous scoring enables “syndrome differentiation and treatment” to be performed in real-time during each pulse acquisition, rather than only triggering during clinical visits.
Scientific Challenges and Limitations
Major Challenges
Challenge 1: Lack of Direct Verification of Organ Harmonic Mapping. Current evidence is predominantly correlational rather than causal experimental. Whether a reduction in C3 harmonic reflects spleen function decline or merely changes in other organs sharing the same sympathetic neural regulation remains unproven directly. This is the core bottleneck for the system’s transition from theory to clinical application.
Challenge 2: Complexity of Individual Differences and Dynamic Baselines. Even in the same healthy individual, the HRI spectrum is significantly modulated by circadian rhythms, menstrual cycles, emotional states, and diet. Establishing a “personalized baseline” requires long-term longitudinal data accumulation, which is costly.
Challenge 3: Conceptual Misalignment Between TCM “Zangfu” and Anatomical Organs. The TCM “spleen” is not equivalent to the anatomical spleen, and the “heart” encompasses mind-spirit functions beyond mere pumping. Establishing effective correspondence rules between biological measurements and TCM theoretical concepts represents a deeper theoretical challenge.
Evidence Level Assessment
Based on existing evidence, the evidence level for using pulse harmonic spectra for continuous Zangfu functional scoring is Level C (preliminary correlational evidence + biologically plausible hypothesis, lacking large-scale prospective validation). Support primarily stems from: ① Cardiovascular harmonic analysis studies on cardiac function correlations (PMID: 33903610, 36294440); ② Microbiome evidence regarding the gut-heart axis (PMID: 35262535, 32451380, 35343188). Transitioning from correlational evidence to independent organ-specific scoring requires extensive rigorous controlled experiments.
Experimental Validation Pathways
Phase 1: Cross-sectional Correlational Study (N=600)
Establish a correlation matrix between HRI spectra and various anatomical organ function indicators (ejection fraction, liver/kidney function, blood glucose, lipids, inflammatory factors), screening for statistically significant harmonic-organ pairings.
Phase 2: Prospective Longitudinal Study (N=200, 12 months)
Track dynamic changes in HRI spectra among patients with chronic diseases (hypertension, type 2 diabetes, chronic liver disease) to verify whether harmonic scores can predict disease progression or treatment response.
Phase 3: TCM Syndrome Differentiation Validation Study (N=300)
Compare the consistency rate between PHZS scores and traditional TCM physician syndrome differentiation types (Kappa statistics) to test whether the hypothesis “TCM syndrome pattern = specific HRI spectrum type” holds true.
Related Reading
- Pulse Harmonics and Organ Frequency Mapping: Re-validation of C1-C10 Based on Machine Learning
- TCM Pulse HRI Characteristics and Retest Reliability
- Wang Weigong Resonance Organ Theory
This article belongs to Pool 3 “Biological Frequency Code” exploration series. For the complete experimental design regarding the “Personalized Zangfu Functional Scoring System Based on Pulse Harmonics,” see P3-EXP-022.
Disclaimer: This article compiles traditional knowledge and scientific literature for comparison and research-design discussion only. It is not medical advice and cannot replace professional diagnosis or treatment. Effect sizes, frequency ranges and exposure conclusions cited here are largely inferences at the research-report level, and individual circumstances vary widely. If you have any discomfort or health concerns, please consult a physician.